Biotech entity
pharma is the sole category represented across all 1 tracked stories. J.B. Chemicals & Pharmaceuticals Ltd. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 4 original sources on average. We currently track 1 Biotech story that mention Unique Pharmaceutical Laboratories, all published on July 21, 2026.
Last mentioned: Jul 21, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. J.B. Chemicals & Pharmaceuticals Ltd. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 4 original sources on average. We currently track 1 Biotech story that mention Unique Pharmaceutical Laboratories, all published on July 21, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 10 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Unique Pharmaceutical Laboratories. Shared-story counts are live from our verified record — not editorial picks.
FDA Recall Notice Published
The U.S. FDA releases a public notice detailing the voluntary recall, classifies it as Class III, and confirms that no adverse incidents have been reported. Distributor Rising Pharma begins customer outreach for returns.
Voluntary Recall Initiated
Unique Pharmaceutical Laboratories initiates a voluntary recall of four lots of cetirizine hydrochloride tablets after discovering misprinted tablet identifiers indicating potential cross-contamination with another medication.
J.B. Chemicals unit Unique Pharmaceutical Laboratories recalls four lots of over-the-counter cetirizine following FDA notice of potential cross-contamination. Though labeled Class III, the error highlights persistent quality-control challenges in the global generic supply chain.
Source: wrno.iheart.com · 1430kasi.iheart.com
Unique Pharmaceutical Laboratories is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
